The Metabolic Syndrome: Epidemiology, Clinical Treatment, and Underlying Mechanisms /
With an extraordinary need for early intervention and prevention to slow or halt its progression, Metabolic Syndrome is one of the most challenging health problems. Only through an understanding of the science underlying this syndrome can successful interventions be developed and implemented. In The...
Saved in:
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2008.
|
| Edition: | 1st ed. 2008. |
| Series: | Contemporary Endocrinology,
|
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-1-60327-116-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 04476nam a22005415i 4500 | ||
|---|---|---|---|
| 001 | 978-1-60327-116-5 | ||
| 003 | DE-He213 | ||
| 005 | 20200701062849.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100505s2008 xxu| s |||| 0|eng d | ||
| 020 | |a 9781603271165 |9 978-1-60327-116-5 | ||
| 024 | 7 | |a 10.1007/978-1-60327-116-5 |2 doi | |
| 050 | 4 | |a RC648-665.2 | |
| 072 | 7 | |a MJG |2 bicssc | |
| 072 | 7 | |a MED027000 |2 bisacsh | |
| 072 | 7 | |a MJG |2 thema | |
| 082 | 0 | 4 | |a 616.4 |2 23 |
| 245 | 1 | 4 | |a The Metabolic Syndrome: |h [electronic resource] : |b Epidemiology, Clinical Treatment, and Underlying Mechanisms / |c edited by Barbara C. Hansen, George A. Bray. |
| 250 | |a 1st ed. 2008. | ||
| 264 | 1 | |a Totowa, NJ : |b Humana Press : |b Imprint: Humana, |c 2008. | |
| 300 | |a XII, 402 p. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Contemporary Endocrinology, |x 2523-3785 | |
| 505 | 0 | |a Metabolic Syndrome—Past and Future -- Metabolic Syndrome—Past and Future -- Epidemilogy And Clinical Treatment: Issues In Defining And Treating The Metabolic Syndrome -- Metabolic Syndrome -- The Role of Obesity in Insulin Resistance -- Treatment of the Metabolic Syndrome with Weight Loss, Exercise, Hormones, and Surgery -- Insulin Resistance, Metabolic Syndrome, and Cardiovascular Disease -- The Sympatho-Adrenal System in the Metabolic Syndrome -- Endothelial Function, Inflammation, and Dyslipidemia -- Insulin Action and Endothelial Function -- Macro- and Microvascular Disease in an Insulin-Resistant Pre-Diabetic Animal Model -- High-Sensitivity C-Reactive Protein and the Metabolic Syndrome -- Insulin Signaling in Adipocytes and the Role of Inflammation -- Insulin Resistance and Dyslipidemia -- Insulin—Secretion and Action: Underlying Mechanisms of the Metabolic Syndrome -- Pancreatic Islet Pathophysiology and Pathology in Obesity -- Glucagon-like Peptides and Insulin Sensitivity -- The Relationship Between the Insulin Receptor Substrates and Metabolic Disease -- Insulin Resistance and Inhibitors of the Insulin Receptor Tyrosine Kinase -- Fat Feeding and Muscle Fat Deposition Eliciting Insulin Resistance -- Alterations in Atypical Protein Kinase C Activation in Insulin Resistance Syndromes -- The Liver, Glucose Homeostasis, and Insulin Action in Type 2 Diabetes Mellitus -- Chronomics of the Metabolic Syndrome. | |
| 520 | |a With an extraordinary need for early intervention and prevention to slow or halt its progression, Metabolic Syndrome is one of the most challenging health problems. Only through an understanding of the science underlying this syndrome can successful interventions be developed and implemented. In The Metabolic Syndrome: Epidemiology, Clinical Treatment, and Underlying Mechanisms, the writers stimulate new thinking concerning underlying mechanisms and encourage heightened efforts to develop new therapeutics, potentially targeting uniquely intersecting pathways. Developing this new synthesis and analysis of the Metabolic Syndrome will bring together the viewpoints of epidemiologists, physiologists, molecular biologists/biochemists, and clinicians toward understanding the current state of knowledge of both the causes and consequences of the Metabolic Syndrome. | ||
| 650 | 0 | |a Endocrinology . | |
| 650 | 0 | |a Diabetes. | |
| 650 | 0 | |a Internal medicine. | |
| 650 | 0 | |a Cardiology. | |
| 650 | 1 | 4 | |a Endocrinology. |0 https://scigraph.springernature.com/ontologies/product-market-codes/H33053 |
| 650 | 2 | 4 | |a Diabetes. |0 https://scigraph.springernature.com/ontologies/product-market-codes/H33045 |
| 650 | 2 | 4 | |a Internal Medicine. |0 https://scigraph.springernature.com/ontologies/product-market-codes/H33002 |
| 650 | 2 | 4 | |a Cardiology. |0 https://scigraph.springernature.com/ontologies/product-market-codes/H33037 |
| 700 | 1 | |a Hansen, Barbara C. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Bray, George A. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9781617377501 |
| 776 | 0 | 8 | |i Printed edition: |z 9781588297389 |
| 830 | 0 | |a Contemporary Endocrinology, |x 2523-3785 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-60327-116-5 |
| 912 | |a ZDB-2-SME | ||
| 912 | |a ZDB-2-SXM | ||
| 950 | |a Medicine (SpringerNature-11650) | ||
| 950 | |a Medicine (R0) (SpringerNature-43714) | ||